HighVista Strategies’s Dynavax Technologies DVAX Stock Holding History

HighVista Strategies’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-192,849	Closed	-$1.91M	–	160
2025 Q3	$1.91M	Buy	192,849 +72,578	+60%	+$755K	0.47%	67
2025 Q2	$1.19M	Sell	120,271 -114,901	-49%	-$1.21M	0.44%	94
2025 Q1	$3.05M	Sell	235,172 -63,364	-21%	-$838K	1.18%	11
2024 Q4	$3.81M	Buy	298,536 +135,828	+83%	+$1.64M	1.42%	8
2024 Q3	$1.81M	Buy	162,708 +6,547	+4%	+$72.2K	0.63%	57
2024 Q2	$1.75M	Hold	156,161	–	–	0.64%	53
2024 Q1	$1.94M	Hold	156,161	–	–	0.69%	48
2023 Q4	$2.18M	Buy	156,161 +23,161	+17%	+$322K	0.79%	41
2023 Q3	$1.96M	Buy	+133,000	New	+$1.87M	0.91%	33
2020 Q4	–	Sell	-14,700	Closed	-$64K	–	124
2020 Q3	$64K	Buy	+14,700	New	+$105K	0.05%	105

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighVista Strategies's DVAX Position: Q4 2025 in Review

HighVista Strategies sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 192,849 shares — an estimated $1.91M sold.

HighVista Strategies first reported a position in DVAX in Q3 2020 and held it in 10 quarters. The position peaked at $3.81M in Q4 2024. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

HighVista Strategies reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
HighVista Strategies sold 192,849 Dynavax Technologies shares in Q4 2025, an estimated $1.91M.
HighVista Strategies first reported a position in Dynavax Technologies in Q3 2020 and held it in 10 quarters.
HighVista Strategies's Dynavax Technologies position peaked at $3.81M in Q4 2024.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on HighVista Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.